Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Wagner

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetesDavid H Wagner, Gisela Vaitaitis, Richard Sanderson, et al.
Journal of Neuroimmunology|August 3, 2014
Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitationGuiying Deng, Jessica Carter, Richard J Traystman, et al.
Journal of Visualized Experiments : Jove|November 9, 2011
Isolation & characterization of Hoechst(low) CD45(negative) mouse lung mesenchymal stem cellsKelsey S Chow, DuHyun Jun, Karen M Helm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
An alternative role for Foxp3 as an effector T cell regulator controlled through CD40Gisela M Vaitaitis, Jessica R Carter, Dan M Waid, et al.
Diabetologia|August 9, 2014
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD miceGisela M Vaitaitis, Michael H Olmstead, Dan M Waid, et al.
Frontiers in Immunology|February 6, 2024
Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulationGisela Vaitaitis, Tracy Webb, Craig Webb, et al.
Journal of Neuroimmunology|April 3, 2014
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cellsDan M Waid, Teri Schreiner, Gisela Vaitaitis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2019
Biomarker Discovery in Pre-Type 1 Diabetes; Th40 Cells as a Predictive Risk FactorGisela M Vaitaitis, Marynette Rihanek, Aimon K Alkanani, et al.
Frontiers in Immunology|March 12, 2026
A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomesGisela M Vaitaitis, Dan M Waid, Christina Sharkey, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetesDan M Waid, Rebecca J Wagner, Amy Putnam, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetesDavid H Wagner, Gisela Vaitaitis, Richard Sanderson, et al.
Journal of Neuroimmunology|August 3, 2014
Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitationGuiying Deng, Jessica Carter, Richard J Traystman, et al.
Journal of Visualized Experiments : Jove|November 9, 2011
Isolation & characterization of Hoechst(low) CD45(negative) mouse lung mesenchymal stem cellsKelsey S Chow, DuHyun Jun, Karen M Helm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
An alternative role for Foxp3 as an effector T cell regulator controlled through CD40Gisela M Vaitaitis, Jessica R Carter, Dan M Waid, et al.
Diabetologia|August 9, 2014
A CD40-targeted peptide controls and reverses type 1 diabetes in NOD miceGisela M Vaitaitis, Michael H Olmstead, Dan M Waid, et al.
Frontiers in Immunology|February 6, 2024
Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulationGisela Vaitaitis, Tracy Webb, Craig Webb, et al.
Journal of Neuroimmunology|April 3, 2014
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cellsDan M Waid, Teri Schreiner, Gisela Vaitaitis, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2019
Biomarker Discovery in Pre-Type 1 Diabetes; Th40 Cells as a Predictive Risk FactorGisela M Vaitaitis, Marynette Rihanek, Aimon K Alkanani, et al.
Frontiers in Immunology|March 12, 2026
A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomesGisela M Vaitaitis, Dan M Waid, Christina Sharkey, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetesDan M Waid, Rebecca J Wagner, Amy Putnam, et al.
Pageof 4